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Introduction
Bacterial sepsis remains the leading cause of death in intensive 
care units. It is a highly dynamic pathological state in which a 
wide array of pro- and antiinflammatory pathways are aberrantly 
activated (1). The resultant clinical outcome is dictated largely by 
the number of organs involved and severity of organ involvement. 
Severe renal failure often sets in gradually and significantly con-
tributes to the mortality of late-phase sepsis (2, 3).
The cellular and molecular pathways involved in sepsis- 
induced organ failure are not well understood. For example, 
examination of postmortem kidney tissue from patients with 
severe sepsis revealed highly heterogeneous and rather nonspe-
cific findings (4). Furthermore, under current clinical practice, 
renal biopsy is rarely performed in patients with sepsis-induced 
kidney injury, contributing to the stagnant progress in this field. To 
date, there are no therapeutic drugs approved for treating sepsis- 
induced organ failure (5).
Broad and unbiased omics, such as transcriptomics and pro-
teomics, are increasingly used to uncover pathways that may 
be involved in the pathogenesis of sepsis. The power of these 
approaches can be further extended if they are used to examine 
omics changes at multiple time points. Indeed, temporal profiling 
is essential because the early and late phases of sepsis differ in 
pathogenesis. Furthermore, the quantitative relationship between 
specific mRNAs and their protein products is not linear and could 
be further distorted by the septic environment. Therefore, an ide-
al strategy could involve the investigation of mRNA and instanta-
neous protein translation, on the same detection scale and range 
(i.e., translatome; ref. 6), and at multiple time points.
In this study, we examined temporal changes in the trans-
latome of the kidney in an animal model of bacterial sepsis. We 
identified translation shutdown as a key feature of late-phase sep-
sis. We further found that 5′ cap–dependent translation shutdown 
is mediated by viral response pathways — originating from a bacte-
rial stimulus. The reversal of this shutdown ameliorates the degree 
of sepsis-induced kidney injury.
Results
Late-phase sepsis is characterized by global protein synthesis shut-
down. A moderate dose of LPS (5 mg/kg) results in robust induc-
tion of proinflammatory cytokines in tissues, including the kidney, 
without causing hemodynamic compromise (7, 8). Thus, this mod-
el is well suited for studying direct LPS effects on organs in vivo. 
Indeed, moderate endotoxemia causes severe acute kidney inju-
ry (AKI) due to direct interaction of LPS with its receptor, TLR4, 
expressed in the S1 proximal tubules (9, 10). The acute phase of 
sepsis-induced AKI (~4 hours) is characterized by tubular oxidative 
stress and tissue-derived proinflammatory cytokines and chemo-
kines (8, 9). Coinciding with this inflammatory outburst, we found 
that the rate of nascent protein synthesis, determined by puromy-
cin incorporation, increased as early as 1 hour after LPS challenge 
(Figure 1A). In contrast, late-phase sepsis (~16 hours) was char-
acterized by global protein synthesis shutdown, which recovered 
spontaneously by 28 hours (Figure 1B). Imaging of nascent protein 
synthesis revealed that the observed changes in the whole-tissue 
lysate occurred primarily in proximal tubules (Figure 1C).
In response to viral pathogens, the host upregulates antiviral genes that suppress translation of viral mRNAs. However, 
induction of such antiviral responses may not be exclusive to viruses, as the pathways lie at the intersection of broad 
inflammatory networks that can also be induced by bacterial pathogens. Using a model of Gram-negative sepsis, we 
show that propagation of kidney damage initiated by a bacterial origin ultimately involves antiviral responses that result 
in host translation shutdown. We determined that activation of the eukaryotic translation initiation factor 2-α kinase 2/
eukaryotic translation initiation factor 2α (Eif2ak2/Eif2α) axis is the key mediator of translation initiation block in late-phase 
sepsis. Reversal of this axis mitigated kidney injury. Furthermore, temporal profiling of the kidney translatome revealed 
that multiple genes involved in formation of the initiation complex were translationally altered during bacterial sepsis. 
Collectively, our findings imply that translation shutdown is indifferent to the specific initiating pathogen and is an important 
determinant of tissue injury in sepsis.
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protein synthesis shutdown 16 hours after LPS administration. 
We found that the majority of proteins involved in vital metabol-
ic pathways, such as the TCA cycle and peroxisome metabolism, 
were downregulated at this time point (Figure 3, A and B). We not-
ed that the ATP/AMP ratio declined after the 16-hour time point, 
suggesting that the loss of energy was the result rather than the 
cause of global translation shutdown (Figure 3, C and D). Inter-
estingly, a small set of genes was found to be resistant to global 
translation shutdown. For example, the levels of Acod1/Irg1, an 
enzyme involved in the synthesis of antimicrobial metabolite 
itaconate, and Nos2, inducible nitric oxide synthase, continued to 
increase over time (Figure 3, A and B). Pathway enrichment anal-
ysis suggests that many of these resistant genes are involved in 
cellular processes, such as mRNA processing and chaperoning of 
protein folding (Supplemental Figure 1, B–D).
In summary, late-phase sepsis is characterized by translation 
initiation block causing translation shutdown that affects critical 
metabolic pathways.
Comprehensive characterization of the translatome in the sepsis 
timeline. To obtain a more mechanistic insight into the temporal 
evolution of translation dysregulation in vivo, we analyzed kidneys 
from septic animals using the Ribo-Seq approach (Supplemental 
Figure 2A). Ribo-Seq provides a global snapshot of actively trans-
We further characterized protein synthesis by performing 
polysome profiling. We found that, in early phase sepsis, there 
were increased monosome and polysome fractions, indicative of 
increased global translation (Figure 1D). In contrast, the profile 
in late-phase sepsis showed sustained monosome fraction, but 
decreased polysome fraction (Figure 1E). This is strongly indica-
tive of translation initiation block (11). Collectively, these findings 
suggest that the rate of translation varies in the sepsis timeline and 
that global translation shutdown is a hallmark of late-phase sepsis.
Nascent proteomics reveals protein synthesis shutdown in major 
metabolic pathways. To further examine global translation shut-
down in late-phase sepsis, we next performed nascent proteom-
ics in which only newly made proteins are labeled, enriched, and 
analyzed by mass spectrometry (Figure 2A and Supplemental 
Figure 1A). This approach offers 2 major advantages over general 
proteomics. First, with the enrichment strategy, excessive signals 
from abundant proteins and background noise are eliminated. 
Second, nascent proteomics provides a snapshot of proteins that 
are currently being synthesized, rather than a cumulative protein 
profile that is confounded by protein half-lives and turnover rates. 
As shown in Figure 2B and Supplemental Table 1 (supplemental 
material available online with this article; https://doi.org/10.1172/
JCI123284DS1), nascent proteomics recapitulated the profound 
Figure 1. Sepsis causes a biphasic translation derange-
ment. (A and B) Time-course analysis of global protein 
synthesis in a murine model of sepsis (LPS, 5 mg/kg 
tail vein, i.v.), as determined by incorporation of puro-
mycin to growing polypeptide chains in vivo. Kidneys 
were harvested 30 minutes after puromycin adminis-
tration at various time points in the sepsis timeline. 
Representative Western blot and its quantification 
are shown. (C) Imaging of nascent protein synthesis in 
kidney tissues using O-propargyl-puromycin (OPP), an 
alkyne analog of puromycin, in vivo. Alexa Fluor 555–
azide was conjugated to OPP by copper(I)-catalyzed 
azide-alkyne cycloaddition (Click chemistry). Prox, 
proximal tubules; dist, distal tubules/collecting ducts. 
Original magnification, ×60. (D and E) Polysomal pro-
filing of kidney extracts from mice treated with LPS for 
indicated durations. Cycloheximide was injected at the 
time of sacrifice to prevent the release of ribosomes 
from the cognate mRNA. Ribosomal subunit 40S, 
60S, mono-ribosome (80S), and polyribosomes were 
separated using sucrose density gradient. (D) Increased 
mono-ribosome and poly-ribosome signals indicating 
increased protein synthesis are observed in the early 
phases of sepsis (LPS, 1, 2, and 4 hours). (E) Increased 
mono-ribosome, but decreased poly-ribosome, frac-
tions indicating initiation block and decreased protein 
synthesis are observed 16 hours after LPS adminis-
tration. Representative UV absorbance traces from 
each time point are overlaid, and for comparison, an 
identical trace (LPS, 4 hours) is shown in both D and 
E. Polysome-to-monosome ratios: 3.0, 3.5, 4.7, 3.1, 1.9, 
and 3.7 at 0, 1, 2, 4, 16, and 28 hours, respectively.
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TLR4 consensus coding sequence (CCDS) is frame 1. The actual 
translating ribosomes are indeed synchronized to frame 1, and the 
ribosomal coverage ends precisely at the stop codon, demonstrat-
ing the high fidelity of ribosome movement (triplet periodicity) 
and high-quality tissue Ribo-Seq data. Figure 4A also shows that 
LPS did not alter TLR4 translation kinetics or translation efficien-
lated mRNAs at single nucleotide resolution (ribosome footprint) 
(6). The position of the ribosome footprint directly correlates with 
the codon that is being translated at the time of tissue harvest. Our 
Ribo-Seq display strategy and quality control measurements are 
shown in Figure 4A and Supplemental Figure 2, B–F. For exam-
ple, we show in Figure 4A that the calculated codon frame of the 
Figure 2. Translation shutdown as determined by nascent proteomics. (A) Overview of nascent proteomics protocol. (B) Approximately 6,000 proteins 
were identified using label-free quantitative mass spectrometry (Supplemental Tables 1 and 2). Principal component analysis biplot illustrating relation-
ships between experimental groups (black) and individual nascent proteins (red) in the 2D space (PC1, PC2). n = 3 for each time point. Median protein 
values are used for data display.
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rich [AU-rich] element binding protein Zfp36 and endonuclease 
Zc3h12a; Supplemental Figure 3).
The subsequent phase of this model of bacterial sepsis was 
characterized by upregulation of antiviral signaling pathways. 
For example, activation of the MyD88-independent TIR domain–
containing adapter-inducing IFN-β (TRIF) pathway leads to the 
induction of IFN and IFN-induced antiviral genes (12). Indeed, 
we found that a wide array of antiviral genes were simultaneous-
ly upregulated at 4 hours and that many of these genes exhibited 
sustained translation up to 28 hours after LPS (Figure 5, A–D, and 
Supplemental Figure 4). These antiviral genes included Zc3hav1, 
Rsad2, and Oas1a, and they played crucial roles in intracellular 
antiviral responses. Expressions of Tlr3 and Cd14, important mol-
ecules that trigger TRIF signaling, were also increased (Figure 
4, E and F). Additionally, the widely used kidney injury marker 
Havcr1/Kim1 — which is a hepatitis A virus receptor — also started 
to increase at 4 hours (Supplemental Figure 4).
In Supplemental Figures 5–12, we show comprehensive 
high-resolution renal translatome analysis in the sepsis timeline. 
The data can be further mined by the scientific community as a 
platform to uncover novel, sepsis timeline–specific therapeutic 
cy (Ribo-Seq to RNA-Seq coverage ratio) in the course of sepsis. 
Additionally, we noted the presence of an upstream open reading 
frame (uORF) (frame 3, blue) that is spanned exactly by corre-
sponding ribosomal reads in the same blue periodicity. This indi-
cates that this uORF is potentially functional. Although discovery 
of encoding uORF is not the focus of this study, we identified a 
number of potentially functional uORFs across the genome in this 
sepsis model, as shown in the subsequent figures.
Analysis of the translatome landscape in sepsis revealed 
major time-dependent changes. We show in Figure 4, B–D, that 
MyD88-dependent NF-κB signaling (the conventional TLR4 
proinflammatory pathway) was immediately activated in vivo. 
NF-κB–induced cytokines, such as IL-6 and IL-1β, were signifi-
cantly increased, both transcriptionally and translationally, 1 
hour after LPS injection (Figure 4). Remarkably, the expression 
of NF-κB–induced genes was rapidly downregulated and returned 
to near baseline levels by 4 hours. This rapid downregulation can 
be explained by the concomitant (rather than sequential) expres-
sion of NF-κB inhibitory molecules at the 1-hour time point (e.g., 
Nfkbia, Tnfaip3, Tnip3; Supplemental Figure 3) as well as upreg-
ulation of the mRNA decay machinery (e.g., adenylate-uridylate–
Figure 3. Multiple metabolic pathways are affected by translation shutdown during late-phase sepsis. (A and B) Nascent proteins detected are 
mapped to the KEGG TCA cycle and peroxisome pathways. Arrowheads point to Acod1/Irg1 and Nos2. (C and D) Representative HPLC chromatograms of 
kidney tissue nucleotides and quantitation of nucleotide ratios are shown. n = 3 per condition. P values determined by Student’s t test (2 sided, non-
paired). Error bars show SD.
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remained unaffected by the treatment, suggesting that their ribo-
somal kinetics are markedly different.
Propagation of TLR4-mediated signaling converges to antiviral 
response pathways that result in global protein synthesis shutdown. 
Although TLR4 is a receptor for LPS in the outer membrane of 
Gram-negative bacteria, our data indicated that pathways involved 
in viral infection are the salient feature of endotoxin-induced kidney 
injury during the subacute to late phases (4 to 16 hours) of sepsis. 
One important mechanism by which the host represses viral repli-
cation is translation shutdown mediated by eukaryotic translation 
initiation factor 2-α kinase 2 (Eif2ak2) (PKR) (15). Eif2ak2 activation 
is triggered by dsRNA binding to Eif2ak2, leading to dimerization 
and autophosphorylation. Activated Eif2ak2 in turn inhibits 5′ cap–
dependent translation via phosphorylation of eukaryotic translation 
initiation factor 2α (eIF2α). Eif2α is the main regulatory subunit of the 
GTP/Met-tRNA ternary complex, a part of the larger translation ini-
tiation complex. Using a cell-culture system, we verified that Eif2ak2 
targets that may be uniquely identifiable by Ribo-Seq. For exam-
ple, we show in Figure 5 that 2 genes in the viral pathway, Mx1 
and Irf7, exhibited a complex translatome profile in which high 
uORF ribosome signal and low translation efficiency became 
prominent during the course of sepsis. This translatome profile is 
consistent with cap-independent translation mechanisms, such 
as those using internal ribosome entry site (IRES) (13). We also 
found that in vivo treatment with lactimidomycin/puromycin, a 
combination of compounds that is used for identification of initi-
ation start sites (14), revealed differential ribosomal kinetics. For 
instance, the antiviral genes Rsad2 and Oas1a have similar trans-
latome features (no uORF, similar 5′ UTR and coding sequence 
(CDS) lengths, similar temporal responses to LPS; Figure 5B and 
Supplemental Figure 4A). Remarkably, however, lactimidomycin/
puromycin treatment resulted in 2 distinct ribosomal coverage 
patterns (Supplemental Figure 13, A and B). The initiation site of 
Rsad2 was highlighted as expected. In contrast, Oas1a ribosomes 
Figure 4. Translatome time course 
reveals propagation of TLR4-mediated 
signaling. (A–F) Ribo-Seq analysis of 
select genes under indicated condi-
tions. Details for data visualization 
strategy are described in Supplemental 
Figure 2. RNA-Seq reads (gray) and 
Ribo-Seq reads (red, blue, green) were 
mapped to the mouse transcriptome. 
The x axes denote mRNA positions 
(position 1 is the start of 5′ UTR and 
x-max position is the end of 3′ UTR). 
The y axes denote read coverage. Green, 
red, and blue colors in the histogram 
correspond to ribosome frames 1, 2, 
and 3, respectively. On the top of each 
control figure (0 hour), calculated ORF 
positions (defined by ATG start codon, 
TAG/TAA/TGA stop codons) and their 
associated frame colors as determined 
by modulo operation are shown. Anno-
tated CCDS is highlighted in light blue 
on the top, and its start and stop posi-
tions are shown on the x axis. When 
multiple isoforms are present, a protein 
coding transcript with best curated 
isoform is shown (e.g., gold transcript 
in Ensembl). All read lengths are dis-
played (median, 29 nt). The color-coded 
vertical bars (red, brown) correspond to 
pathways highlighted in Figure 5J.
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activation causes Eif2a phosphorylation and that Eif2ak2 inhibition 
prevents Eif2α phosphorylation (Supplemental Figure 13C).
Accordingly, we hypothesized that the global translation 
shutdown observed in the LPS model could be due to activation 
of this antiviral response pathway. Indeed, we found that in vivo 
expression levels of Eif2ak2 increased at 4 hours after LPS injec-
tion and remained elevated, coinciding with the time at which 
antiviral response genes were upregulated (Figure 5, E and F, and 
Figure 6, A and B). We also found that phosphorylation of Eif2α 
started to increase at 4 hours (Figure 6A). These changes sug-
Figure 5. Propagation of TLR4-mediated 
signaling elicits antiviral response path-
ways. (A–I) Ribo-Seq analysis of select genes 
involved in viral response and Eif2ak2 (PKR) 
activation. Ribo-Seq reads (red, green, blue) 
are superimposed as a front layer over RNA-
Seq reads (gray). (J) Schematic of TLR4- 
mediated signaling pathways is shown. The 
background colors correspond to the colors 
of vertical bars in Figure 4 (red, brown) and 
Figure 5 (beige, blue).
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gest that Eif2ak2-mediated inactivation of the Eif2 complex con-
tributed to the deleterious global translation shutdown. Impor-
tantly, none of the other Eif2α kinases, namely Eif2ak1 (HRI), 
Eif2ak3 (PERK), and Eif2ak4 (GCN2), showed changes in their 
translatome profiles, suggesting that Eif2α phosphorylation was 
specifically induced by Eif2ak2, the antiviral response gene (Sup-
plemental Figure 13, D–G). In addition, the translation of Eif2ak2 
phosphatases Ppp1r15a (Gadd34) and Ppp1r15b (CreP) remained 
unchanged (despite the increased mRNA expression in the case 
of Gadd34), which in effect could also contribute to the sustained 
phosphorylation of Eif2α (Figure 5, G and H). Collectively, these 
changes support a role for the Eif2ak2/Eif2α axis in mediating 
global translation shutdown. Phosphorylated Eif2α (p-Eif2α), in 
turn, was implicated in the activation of the stress responsive Atf4 
pathway, known to be involved in either recovery or abortive gene 
activation (Figure 5, I and J, and Supplemental Figure 14, A–E). 
The lack of translational activation of proapoptotic Ddit3 (CHOP) 
might indicate a preponderance of recovery activities in the late 
phase of the sublethal LPS model (Supplemental Figure 14D).
Finally, to demonstrate the causal role of translation shut-
down in inducing AKI, we used the integrated stress response 
inhibitor (ISRIB), a compound that stabilizes the guanine nucleo-
tide exchange factor Eif2b in an activated state, thereby rescuing 
translation despite the presence of p-Eif2α (16, 17). When given 
early in the course of sepsis in vivo, ISRIB reversed the effect of 
p-Eif2α on translation and led to significant renoprotection with-
out affecting the levels of Eif2ak2, Eif2α, or p-Eif2α (Figure 6, C–E, 
and Supplemental Figure 15A). Ribo-Seq analysis revealed that 
ISRIB increased translation of multiple genes involved in general 
metabolism as well as genes that are indispensable for effective 
transcription and translation, such as Med13l (a component of the 
RNA polymerase II mediator complex), Taf4b (a subunit of RNA 
polymerase II preinitiation complex), and Eef1g (eukaryotic trans-
lation elongation factor 1G; Figure 7, A–C, and Supplemental Figure 
15, B and C). In contrast, Nrf1 translation was reduced in animals 
that received ISRIB (Figure 7A). Nrf1 is a direct transcription factor 
of Eif2α. The reduced Nrf1 expression is likely through a negative 
feedback mechanism in response to increased overall translation 
in the ISRIB-treated animals. The overall cytokine/chemokine 
profiles were similar between animals treated with and without 
ISRIB (Supplemental Figure 15, D and E). Additionally, we show 
in Supplemental Figure 15, F and G, that the inhibition of Eif2ak2 
by 2-aminopurine or C16 (thereby limiting Eif2α phosphorylation; 
refs. 18, 19) afforded renoprotective effects comparable to those 
observed with ISRIB treatment. Finally, we show in Supplemental 
Figure 15, H and I, that ISRIB prevented translation shutdown and 
conferred renoprotection in a model of polymicrobial sepsis using 
cecal ligation and puncture. Note that, when given at later time 
points, ISRIB and 2-aminopurine were ineffective. We show in the 
next section that this lack of therapeutic effects at later time points 
is due in part to the emergence of Eif2α-independent mechanisms 
that inhibit translation. This underscores the importance of tim-
ing therapy in the dynamic timeline of sepsis. Furthermore, while 
timely and transient reversal of translation shutdown is protective, 
chronic inhibition of Eif2α phosphorylation may have deleterious 
effects. This is because, as noted above, Eif2α phosphorylation is 
also involved in the adaptive stress-responsive Atf4 pathway.
In summary, we showed that Eif2ak2/Eif2α-mediated trans-
lation shutdown is an important contributor to sepsis-induced 
kidney injury. To extend the findings, we also performed laser 
and manual microdissection of S1 and S2/S3 proximal tubular 
segments, respectively, and obtained transcriptomics analysis 
(Figure 7, D–G). We found that the bulk kidney Eif2ak2 signal spe-
cifically originated from S2/S3 proximal tubules. S2/S3 are indeed 
Figure 6. Translation shutdown mediated by the Eif2ak2/Eif2α axis contributes to sepsis-induced kidney injury. (A) Mice were treated with 5 mg/kg 
LPS i.v. for indicated durations, and kidneys were analyzed by Western blot for Eif2ak2, Eif2α, and Ser51 p-Eif2α (arrow). (B) Select protein levels as deter-
mined by nascent proteomics are shown. (C and D) In vivo effects of ISRIB (5 mg/kg i.p.) on protein synthesis (puromycin incorporation in the kidney; ISRIB 
for 16 hours) and tissue expression of Eif2ak2, Eif2α, and p-Eif2α (kidneys harvested 16 hours after 5 mg/kg LPS i.v. with or without ISRIB i.p. for 16 hours). 
LPS increased Eif2ak2 and p-Eif2α. This increase was not affected by ISRIB. (E) Serum creatinine levels 24 hours after LPS with or without ISRIB treatment 
administered at indicated time points. *P < 0.05 vs. LPS without ISRIB treatment by Student’s t test (2 sided, nonpaired). Error bars show SD.
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highly regulated process that requires assembly of multiple sub-
units in a specific order. Therefore, sustained phosphorylation of 
Eif2α could sufficiently explain the global translation shutdown 
in sepsis. However, the narrow therapeutic window of ISRIB and 
2-aminopurine suggested that dysregulation of other components 
the main cell types that exhibit LPS-induced injury in vivo, as we 
previously reported (9, 10, 20). Nevertheless, the role of Eif2ak2 in 
other cell types cannot be ruled out.
Multiple mechanisms contribute to translation shutdown in late-
phase sepsis. The formation of the 5′ cap initiation complex is a 
Figure 7. ISRIB reverses the effect of p-Eif2α on translation. (A) Ribo-Seq analysis of kidney extracts from mice treated with LPS for 16 hours with or 
without ISRIB. Smear plot in which top 10 differentially translated genes are highlighted in red (edgeR exactTest with BH adjusted P values < 0.05, n = 3 
per condition). The x axis denote mean log counts per million (logCPM), and the y axis denotes log fold change (logFC). ISRIB was administered 1 hour after 
LPS. (B and C) Comparative translatome count values mapped to the TCA cycle and peroxisome pathways. (D) S1 proximal tubules from kidneys of control 
or septic mice were laser microdissected. Original magnification, ×60. Glom, glomerulus. (E) S2/S3 proximal tubules from indicated conditions were man-
ually microdissected. Original magnification, ×5. (F and G) Transcriptomics analysis was performed on S1 and S2/S3 segments (n = 4 for each condition). 
Select gene expression levels are shown. P values were determined by Student’s t test (2 sided, nonpaired). The boxplot middle line shows the median, the 
box edges show the 25th and 75th percentiles, and the whiskers show the ×1.5 interquartile range.
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of uORFs (21). Thus, the decreased expression of Mcts1 observed 
in sepsis (Figure 8D) could have broad repressive effects on mul-
tiple genes that harbor ribosome-engaged uORFs (e.g., Mx1, Irf7, 
Eif2ak2, Ppp1r15a, Ppp1r15b, Atf4 in Figure 5; Zc3h12a in Supple-
mental Figure 3; Plvap, Kdr in Supplemental Figure 9; Nphs1 in 
Supplemental Figure 10; Sesn2, Ddit3 in Supplemental Figure 14; 
Eif4g2 in Supplemental Figure 16). We also noted that Eif6 expres-
sion level was increased and remained elevated at 28 hours (Fig-
ure 8E). Eif6 is a multifaceted molecule that prevents the associa-
tion of 60S and 40S ribosomal subunits to form the 80S initiation 
complex. Interestingly, such an antiassociation factor is reported 
to promote translation under certain experimental conditions 
(22, 23). Whether the increased level of Eif6 in our sepsis model 
reflects compensatory or recovery response to translation shut-
of the initiation complex might also contribute to depressed trans-
lation. Indeed, we found that translation of cap-binding protein 
Eif4e was decreased even though the mRNA level was unaffect-
ed (Figure 8A). We also found that Eif4ebp3, a repressor of Eif4e 
assembly to the cap complex, was increased (Figure 8B). In addi-
tion, the RNA helicase Eif4a2 was translationally downregulated 
(Figure 8C and Supplemental Figure 12E). Taken together, the 
changes in these components can also repress the early steps of 
cap-dependent translation initiation (eIF4F complex formation; 
Figure 8G and Supplemental Figure 16).
Outside of the core cap machinery, late-phase sepsis was also 
associated with changes in noncanonical initiation factors. Malig-
nant T cell amplified sequence 1 (Mcts1) was recently reported to 
be an important regulator of translation reinitiation downstream 
Figure 8. Multiple mechanisms contribute to translation shutdown in late-phase sepsis. (A–F) Ribo-Seq analysis of select genes involved in translation 
(in mice). (A) For clarity, the layer order for Eif4e was reversed, with RNA-Seq reads (gray) shown as front layer (right 2 panels). (G) Schematic of the 5′ 
cap initiation complex.
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scriptomic signatures of biopsies from sepsis versus non–sepsis- 
related AKI were also indistinguishable (Figure 9A). However, we 
found that expression of EIF2AK2 (but not other EIF2AK genes) 
was increased in patients with sepsis, especially so in the patient 
with prolonged and recurrent sepsis (Figure 9G). Thus, EIF2AK2 
could potentially be a useful sepsis-specific kidney injury marker 
and help further stratify the sepsis timeline. Multiple other genes 
in the human renal biopsies from sepsis-related AKI also exhib-
ited time-specific changes that paralleled those observed in the 
mouse translatome (Figure 9, B–I; Supplemental Figures 5 and 6 
for mice). Note that, although the sepsis timeline could be divid-
ed into early and late phases in both humans and mice, the actual 
time scale is likely different between the 2 species. Furthermore, 
defining early and late sepsis is difficult when comparing single–
time-point data from different patients. More robust conclusions 
can be made when data are obtained from one patient at various 
points in the sepsis timeline.
Discussion
The development of kidney injury in sepsis is a clinical tipping 
point, after which the survival rate severely declines. The mech-
anisms of the downward spiral leading to complete organ failure 
and death are poorly understood. The current paradigm views 
inflammation as the centerpiece of sepsis pathology (1, 5, 26–28). 
However, this paradigm falls short of connecting inflammation 
to the phenomenon of terminal “total organ shutdown.” Using 
high-resolution translatomics and nascent proteomics, we dis-
down remains to be determined. We also show in Figure 8F that the 
pre-mRNA cap–binding molecule Ncbp2 levels decreased over the 
course of sepsis. This could negatively affect the kinetics of nascent 
mRNAs and their pioneer round of translation in the nucleus (24).
Finally, the burst of protein synthesis during the early phase 
of sepsis could cause ER stress and contribute to the global trans-
lation shutdown. Indeed, we show in Supplemental Figure 16F, 
that Xbp1, a characteristic marker for ER stress, was increased at 
4 hours and remained elevated up to 28 hours. More specifically, 
activation of Xbp1 requires unconventional splicing, which induc-
es a frameshift and generates a read-through protein product (25). 
Ribo-Seq clearly illustrated the genesis of the spliced Xbp1 iso-
form (Supplemental Figure 16, G and H).
In aggregate, high-resolution translatome analysis provided a 
framework for analyzing the previously underappreciated transla-
tion shutdown that characterizes late-phase sepsis and highlight-
ed potential therapeutic targets.
EIF2AK2 expression is increased in kidneys from patients with 
sepsis-induced AKI. Finally, we asked whether human sepsis– 
related AKI has a signature comparable to the one found in the 
murine model. We obtained archived kidney biopsy samples 
showing a primary pathologic diagnosis of acute tubular necrosis 
(ATN). From these biopsy samples, we identified 5 cases of bac-
terial sepsis and 10 various non–sepsis-related cases (Figure 9K 
and Supplemental Table 3). The histopathology of sepsis-induced 
kidney injury was indistinguishable from that of other causes of 
ATN. We performed RNA-Seq and found that the overall tran-
Figure 9. Eif2ak2 expression is increased in the kidneys of septic patients. (A–I) RNA-Seq was performed on archived human kidney biopsy samples with 
final pathologic diagnosis of ATN. These samples were divided into 2 groups based on clinical information: sepsis-related AKI and non–sepsis-related AKI 
(referred to as others; Supplemental Table 3). Sepsis* refers to 1 patient in the sepsis-related AKI group who had prolonged and repeated episodes of sepsis. 
Serum creatinine from these patients is shown in J. P values were determined by Student’s t test (2 sided, nonpaired). The boxplot middle line shows the 
median, the box edges show the 25th and 75th percentiles, and the whiskers show ×1.5 interquartile range. (K) Overview of human kidney biopsy analysis.
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saline s.c. No antibiotics were used. ISRIB (5 mg/kg, diluted in DMSO) 
was administered i.p. at the time of abdominal closure. The following 
reagents were also used in vivo under indicated experiments: puro-
mycin (40 mg/kg i.p.; MilliporeSigma), O-propargyl-puromycin (an 
alkyne analog of puromycin, 40 mg/kg i.p.; Jena Bioscience), lac-
timidomycin (1 mg/kg i.p., stock in DMSO, diluted in saline; Milli-
poreSigma), ISRIB (5 mg/kg i.p., diluted in DMSO, MilliporeSigma), 
2-aminopurine (10 mg/kg i.p., stock in PBS/glacial acetic acid 200:1, 
diluted in saline; MilliporeSigma), and C16 (0.16 mg/kg i.p., stock in 
DMSO; MilliporeSigma). RAW 264.7 murine macrophage cells were 
cultured using high-glucose DMEM with 10%FBS and treated with 
LPS (500 ng/ml), 2-aminopurine (1 mM), polyinosinic:polycytidylic 
acid (poly[I:C]) (50 μg/ml), or their vehicles.
Click chemistry and immunofluorescence microscopy. Mice were 
injected with O-propargyl puromycin (40 mg/kg) i.p. 30 minutes 
before tissue harvest. Kidneys were fixed with 4% paraformaldehyde, 
sectioned (10 μm), and deparaffinized. Tissues were incubated for 
30 minutes with 100 mM Tris Base, 1 mM CuSO4, 100 mM ascorbic 
acid, 100 μM Alexa Fluor 555 azide (Molecular Probes), and 0.2% 
Triton X-100 at room temperature (34). Tissues were then washed in 
PBS with 0.1% Triton X-100 for 30 minutes 3 times, counterstained 
with DAPI for 10 minutes, washed in PBS 3 times, and imaged with an 
Olympus FV1000-MPE confocal/multiphoton microscope.
Western blotting. For in vivo puromycin incorporation into nascent 
proteins, mice were injected with puromcyin (40 mg/kg) i.p. and tis-
sues were harvested 30 minutes later. Tissues were extracted with 
RIPA buffer with an additional 5 mM EDTA, 5 mM EGTA, Halt pro-
tease inhibitors (Pierce), phosStop inhibitor (Roche), and benzonase 
nuclease (EMD Millipore). Total protein levels were determined using 
a modified Lowry assay (Bio-Rad). Equal amounts of kidney proteins 
(20 μg), and in some cases, equal volumes of extracts per kidney, 
were mixed with NuPAGE LDS Sample Buffer (Thermo Fisher Sci-
entific) with 100 mM of DTT and separated by electrophoreses on 
NuPage 4%–12% Bis-Tris gels and transferred to PVDF membranes. 
Antibodies used included the following: anti-puromycin antibody 
(1 μg/ml; Developmental Studies Hybridoma Bank), PKR–Alexa Fluor 
680 (B-10, Santa Cruz Biotechnology Inc., catalog sc-6282), p-eIF2α 
(Ser51, Invitrogen, catalog PIPA537800), eIF2α (Cell Signaling Tech-
nology, catalog 9722), ATF4 (Creb2) Alexa Fluor 680 (B-3, Santa Cruz 
Biotechnology Inc., catalog sc-390063), and histone H3 (Cell Signal-
ing Technology, catalog 9715).
Polyribosomal profiling. For polyribosome profiling of kidney tis-
sues, cardiac perfusion was performed with 6 ml of cycloheximide 
(100 μg/ml in PBS). Harvested kidneys were immediately placed in a 
lysis buffer consisting of 1% Triton X-100, 0.1% deoxycholate, 20 mM 
Tris-HCl, 100 mM NaCl, 10 mM MgCl2, EDTA-free Protease Inhib-
itor Cocktail Tablet (Roche), 50 μg/ml cycloheximide, and RNAsin 
(1:500 dilution). Tissues were homogenized at 4°C using a Precellys 
tissue homogenizer. Tissue homogenates were incubated on ice for 10 
minutes, then centrifuged at 9,600 g for 10 minutes. The supernatant 
was added to the top of a sucrose gradient generated by BioComp Gra-
dient Master (10% sucrose on top of 50% sucrose in 20 mM Tris-HCl, 
100 mM NaCl, 5 mM MgCl2, and 50 mg/ml cycloheximide) and cen-
trifuged at 283,800 g for 2 hours at 4°C. The gradients were harvested 
from the top in a Biocomp harvester (Biocomp Instruments), and the 
RNA content of eluted ribosomal fractions was continuously moni-
tored with UV absorbance at 254 nm.
sected a chain of events that was initiated by a defined single- 
entry point (i.e., the interaction of LPS and its receptor TLR4). 
This interaction resulted in extensive dynamic changes in the 
translatome landscape. Upregulation of the conventional MyD88- 
dependent NF-κB pathway was characteristic of the early phase 
of sepsis (1 hour). This was followed by activation of the MyD88- 
independent TRIF pathway, which led to the production of vari-
ous antiviral proteins (4 hours). This “viral response phase” was 
prolonged, possibly through the sustained upregulation of ampli-
fiers of TRIF signaling, such as CD14, as well as crosstalk between 
endogenous nucleotide fragments and cytoplasmic or endosomal 
viral sensors such as RIG-1 and TLR3. Activation of Eif2ak2 and 
other antiviral genes resulted in cap-dependent translation shut-
down in late-phase sepsis (16 hours). This role of Eif2ak2 in sepsis 
extends its other well-described functions, such as those related 
to inflammasome biology (29). We propose that such global trans-
lation shutdown is an important cause of organ failure in sepsis.
Our analysis of the translatome using Ribo-Seq data revealed 
various changes in the expression of uORFs in specific genes during 
sepsis. The functional properties of uORFs are largely unknown 
and require detailed molecular investigation for each gene (30). 
This is because the regulation is believed to be specific to each 
cognate 5′ UTR mRNA structure (31–33). Functions ascribed to 
uORFs include slowing down the translation of CDS, creating a 
nidus to facilitate the recruitment of the initiation complex, and 
in some cases, acting as a source of short peptides that regulate 
translation. Elucidating specific functions of uORFs could contrib-
ute to novel therapeutic approaches to controlling inflammation 
and translation.
In humans, translatome analysis of renal biopsy samples is 
yet to be established. Indeed, special protocols need to be imple-
mented that will allow rapid and efficient handling of the biopsy in 
order not to lose information about highly time-sensitive events, 
such as ribosomal mRNA dynamics. Nevertheless, our transcrip-
tomics analysis of available human biopsy samples correlated well 
with the mouse translatome data, especially for genes that are reg-
ulated transcriptionally. As expected, the scale of the sepsis time-
line differs between rodents and humans. However, the relative 
changes over time were comparable. Cell-type–specific responses 
could not be determined due to the use of bulk tissue.
In conclusion, combined examination of the translatome, 
transcriptome, and nascent proteome provides a new platform 
that allows the identification of temporal aberration of inflamma-
tion and translation in sepsis. Our data support a model in which 
upregulation of antiviral response pathways links the early prop-
agation of inflammation to systemic translation shutdown in the 
later phases of sepsis.
Methods
Animals and cells. Male mouse strain C57BL/6J was obtained from the 
Jackson Laboratory. Mice were 8–12 weeks of age and weighed 20–30 
g. Animals were subjected to a single-dose, 5 mg/kg LPS tail vein i.v. 
injection (E. coli serotype 0111:B4, MilliporeSigma). Untreated mice 
received an equivalent volume of sterile, normal saline vehicle. Cecal 
ligation and puncture were performed under isoflurane anesthesia; 
75% of the mouse cecum was ligated and punctured twice with a 
27-gauge needle. Animals were resuscitated with 500 μl of normal 
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mM HEPES, 0.1% BSA; pH 7.4) using a Leica MZ 12.5 stereomicro-
scope equipped with a Leica MC 170 HD digital microscope camera 
and ThermaZone cooling device, as described previously (10). RNA 
was extracted using the PicoPure RNA Kit (Life Technologies). For 
S1 proximal tubule laser microdissection, kidney sections (10 μm 
thick) were placed on polyphenylene sulfate membrane slides (Leica). 
Immunofluorescence staining was performed as described previously, 
and dissection was performed on a Leica LMD6000 microscope (10). 
S1 segments were recognized as they extended from Bowman’s space. 
Three consecutive sections (from the same kidney tissue) were pooled 
to increase the amount of RNA. RNA extraction was done using the 
PicoPure Kit (Applied Biosystems). RNA was labeled using the stan-
dard protocol for the Affymetrix WT Pico kit. Individually labeled 
samples were hybridized to the Mouse Gene 2.0 ST GeneChips for 17 
hours, then washed, stained, and scanned with the standard protocol, 
using Affymetrix GeneChip Command Console software.
PCR. RNA extraction from snap-frozen kidneys was performed 
using TRIzol, and the extracted RNA was reverse-transcribed using the 
High Capacity cDNA Reverse Transcription Kit (Life Technologies). 
TaqMan gene expression assays used included kidney injury mole-
cule-1 (Mm00506686_m1) and glyceraldehyde-3-phosphate dehy-
drogenase (Mm99999915_g1). Real-time quantitative PCR ampli-
fications were performed for 40 cycles using ViiA 7 Real-Time PCR 
systems. The ΔΔCt method was used to analyze the relative changes 
in gene expression. For Xbp1 PCR, the following primers were used: 
Xbp1F: AGTTAAGAACACGCTTGGGAAT; Xbp1R: AAGATGTTCT-
GGGGAGGTGAC; S-Xbp1F: CTGAGTCCGAATCAGGTGCAG; and 
S-Xbp1R: GTCCATGGGAAGATGTTCTGG
Metabolomic profiling. Metabolomic analysis was performed at 
Metabolon Inc. Snap-frozen kidney tissues were processed following 
the Metabolon standard extraction method (60% methanol). The 
extracts were analyzed by gas chromatography–mass spectrometry 
and ultra-high performance liquid chromatography–tandem mass 
spectrometry platforms.
Human kidney biopsy and RNA-Seq. Archived kidney biopsy sam-
ples were retrieved from the Indiana Biobank. The database was 
queried for primary pathology diagnoses of ATN, and 15 cases were 
selected after excluding solid organ transplant and liver-failure cases. 
Of those 15 cases, 5 were found to have documented sepsis. Bulk tis-
sues were subjected to RNA-Seq at the Indiana University Center for 
Medical Genomics Core. The Illumina TruSeq RNA Access Library 
Prep Kit was used for library construction. Sequences were performed 
with 2 × 75 bp paired-end configuration on HiSeq4000 using a HiSeq 
3000/4000 PE SBS Kit (Illumina), and the sequenced data were 
mapped to the hg38 human genome using the STAR RNA-Seq aligner.
Cytokine/chemokine multiplex. Analysis of kidney homogenate 
cytokines/chemokines was performed using Milliplex MAP Mouse 
Cytokine/Chemokine Magnetic Bead Panel–Premixed 32 Plex (MCYT-
MAG-70K-PX32; Millipore). Proteins were extracted with RIPA buffer, 
and total protein concentrations were adjusted to 0.4 μg/μl per well 
according to the manufacturer’s instructions. Analysis was performed 
by the Multiplex Analysis Core at Indiana University.
Data analysis. Data were analyzed for statistical significance and 
visualization with R software 3.4.3. The following packages were used: 
ggbiplot (Figure 2B); levelplot (Figure 6B, Supplemental Table 1, Sup-
plemental Figure 5G); Pathview (Figure 3, A and B, and Figure 7, A and 
B); hclust (euclidean, ward.D) and cutree (Supplemental Figure 1B, 
Nascent proteomics. Mice were injected with LPS i.v. at indicated 
time points, and O-propargyl puromycin (40 mg/kg) was injected i.p. 
30 minutes before sacrifice. One kidney from each animal was homog-
enized in cold RIPA lysis buffer with protease inhibitor cocktail and 
benzonase, incubated on ice for 10 minutes, and centrifuged at 9,600 g 
for 10 minutes. Supernatants were mixed with 8M urea and processed 
for copper-based Click chemistry reaction using a Click-&-Go Protein 
Enrichment Kit (Click Chemistry Tools, 1151). Samples were incu-
bated in the copper catalyst solution with azide-agarose resin for 16 
hours, followed by rigorous washing, including SDS ×5, 8M urea ×10, 
and 20% acetonitrile ×10. Enriched proteins were digested directly 
from the resin, and two-thirds of the recovered volume of nascent pro-
teins obtained from each kidney were submitted for mass spectrom-
etry analysis. Label-free quantitative analysis was performed using 
the Orbitrap Fusion Lumos Tribrid mass spectrometer at the Indiana 
University Proteomics Core.
HPLC. To extract nucleotides, one kidney from each anesthe-
tized mouse was removed and immediately immersed in liquid 
nitrogen. Kidneys were pulverized under liquid nitrogen with mor-
tar and pestle and suspended in 30% ice-cold acetonitrile. Superna-
tants were gassed with nitrogen gas to evaporate acetonitrile, and 
the nucleotide levels were measured by HPLC (Agilent 1100 series) 
with a UV detector at 254 nm. The HPLC buffer consisted of 2 mM 
Paired-Ion Chromatography Reagent A (Waters), 10 mM ammonium 
phosphate, and 20% acetonitrile, and the buffer was run isocratically 
at 2 ml/min. The column used was a Nova-Pack C18 4-μm, 8 × 100 
mm Radial-Pak Cartridge (Waters).
Ribo-Seq analysis. Kidneys were snap-frozen and pulverized 
under liquid nitrogen. In some experiments, 1 mg/kg lactimidomy-
cin and 40 mg/kg puromycin were administered i.p., 30 minutes and 
15 minutes before sacrifice, respectively. Cryo-lysis was done using a 
Precellys tissue homogenizer in a polysome buffer consisting of Illu-
mina TruSeq Polysome Buffer, Riboguard (Lucigen), Triton X-100, 
DTT, DNAse I, cycloheximide, and NP40. Tissue lysates were cen-
trifuged at 20,000 g for 10 minutes. Equal volumes of supernatant 
aliquots were made for Ribo-Seq and RNA-Seq workflows (35). RNA 
concentration was determined using Qubit assays. Polysome diges-
tion was performed in polysome buffer without detergent (20 mM 
Tris, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 100 μg/ml cyclohexim-
ide, 50 U Lucigen RNase-I) for 45 minutes at room temperature, and 
the reaction was stopped with 10 μl SUPERase (Thermo Fisher Scien-
tific). Ribosome-protected fragments were isolated using 1M sucrose 
cushion plus 20 U/ml SUPERase, and centrifuged at 541,700 g at 4°C 
in a TLA100.4 rotor using thick wall polycarbonate tubes (Beckman) 
for 1 hour. RNA fragments were purified from TRIzol resuspended 
ribosomal pellets using the Direct-zol kit and treated with T4 poly-
nucleotide kinase to heal the 2′ to 3′ cyclic phosphate. We then pro-
ceeded with adaptor ligation and standard library construction steps. 
Ribosomal RNAs were depleted using Ribo-Zero Gold (Illumina). 
Sequencing was performed at Cofactor Genomics using Illumina 
NextSeq 500 (approximately 70 million reads per library, single-end 
75 bp reads). Mapping was done using bowtie2 against the mm10 
transcriptome as well as the mm10 genome.
Manual and laser microdissection and microarray analysis. Mouse 
kidneys were sliced, and tubular microdissection was performed in 
ice-cold dissection solution (135 mM NaCl, 1 mM Na2HPO4, 1.2 mM 
Na2SO4, 1.2 mM MgSO4, 5 mM KCl, 2 mM CaCl2, 5.5 mM glucose, 5 
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